In last trading session, Nextcure Inc (NASDAQ:NXTC) saw 0.32 million shares changing hands with its beta currently measuring 1.06. Company’s recent per share price level of $0.46 trading at $0.04 or 9.79% at ring of the bell on the day assigns it a market valuation of $12.88M. That closing price of NXTC’s stock is at a discount of -295.65% from its 52-week high price of $1.82 and is indicating a premium of 52.17% from its 52-week low price of $0.22. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.27 million shares which gives us an average trading volume of 129.10K if we extend that period to 3-months.
For Nextcure Inc (NXTC), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.4 in the current quarter.
Nextcure Inc (NASDAQ:NXTC) trade information
Upright in the green during last session for gaining 9.79%, in the last five days NXTC remained trading in the green while hitting it’s week-highest on Friday, 04/25/25 when the stock touched $0.46 price level, adding 7.82% to its value on the day. Nextcure Inc’s shares saw a change of -40.34% in year-to-date performance and have moved 27.35% in past 5-day. Nextcure Inc (NASDAQ:NXTC) showed a performance of -13.45% in past 30-days. Number of shares sold short was 58978.0 shares which calculate 0.7 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 3 to the stock, which implies a rise of 84.67% to its current value. Analysts have been projecting 3 as a low price target for the stock while placing it at a high target of 3. It follows that stock’s current price would drop -552.17% in reaching the projected high whereas dropping to the targeted low would mean a loss of -552.17% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 1.53% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 12.06% while estimates for its earnings growth in next 5 years are of 19.45%.
Nextcure Inc (NASDAQ:NXTC)’s Major holders
Insiders are in possession of 7.01% of company’s total shares while institution are holding 52.29 percent of that, with stock having share float percentage of 56.23%. Investors also watch the number of corporate investors in a company very closely, which is 52.29% institutions for Nextcure Inc that are currently holding shares of the company. SOFINNOVA INVESTMENTS, INC. is the top institutional holder at NXTC for having 2.67 million shares of worth $4.25 million. And as of 2024-06-30, it was holding 9.5516 of the company’s outstanding shares.
The second largest institutional holder is LOGOS GLOBAL MANAGEMENT LP, which was holding about 2.5 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.9373 of outstanding shares, having a total worth of $3.98 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Federated Hermes MDT Series-Federated Hermes MDT Small Cap Growth Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 613.83 shares of worth $0.28 million or 2.19% of the total outstanding shares. The later fund manager was in possession of 315.18 shares on Jan 31, 2025 , making its stake of worth around $0.14 million in the company or a holder of 1.12% of company’s stock.
